Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2021 September;63(3) > Panminerva Medica 2021 September;63(3):382-3

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

LETTERS TO THE EDITOR   

Panminerva Medica 2021 September;63(3):382-3

DOI: 10.23736/S0031-0808.19.03685-1

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

MAGEA3 serves as an independent indicator for predicting the prognosis of ESCC

Shenxiang LIU 1, 2, Hongyan CHEN 3, Xiaolin GE 1, Zhenzhen GAO 4, Yu SHI 1, Min YANG 1, 5

1 Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 2 Department of Oncology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China; 3 Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 4 Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 5 Molecular Imaging Center, Jiangsu Institute of Atomic Medicine, Wuxi, China



inizio pagina